MR. THOMAS JAMES LOVELESS MSN, CRNP, PHD
Prescription History 1730185521
Nurse Practitioner - Adult Health in Southampton, PA
Medicare Part D Prescription History
Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for MR. THOMAS JAMES LOVELESS MSN, CRNP, PHD, an active Adult Health specialist practicing in Southampton, PA. Our medical registry currently tracks 14 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 694 documented patient claims. Among these therapy options, the most frequently utilized medication is Biktarvy, which accounts for 200 claims alone. Use the table below to sort by claims, cost, or utilization compared with the state average; select any medication for its full profile.
| Medication | Prescriptions (2023)Rx (2023) | Avg Cost per FillCost / Fill | Vs. Other PA PrescribersVs. PA Avg |
|---|---|---|---|
| BiktarvyBictegrav/Emtricit/Tenofov Ala | 200 | $3,998.56 | ▲ More than typical |
About Biktarvy: This combination product is used by itself to help control HIV infection. Show more ▾ It helps to decrease the amount of HIV in your body so your immune system can work better. This lowers your chance of getting HIV complications (such as new infections, cancer) and improves your quality of life. This product is a combination of 3 different drugs: bictegravir, emtricitabine, and tenofovir alafenamide. Bictegravir is called an integrase strand transfer inhibitor-INSTI. Emtricitabine is called a nucleoside reverse transcriptase inhibitor, while tenofovir alafenamide is called a nucleotide reverse transcriptase inhibitor. Emtricitabine and tenofovir alafenamide are often called NRTIs. Bictegravir/emtricitabine/tenofovir alafenamide is not a cure for HIV infection. To decrease your risk of spreading HIV disease to others, continue to take all HIV medications exactly as prescribed by your doctor. Use an effective barrier method (latex or polyurethane condoms/dental dams) during sexual activity as directed by your doctor. Do not share personal items (such as needles/syringes, toothbrushes, and razors) that may have contacted blood or other body fluids. Consult your doctor or pharmacist for more details. In 2023, this provider wrote 200 Medicare prescriptions for Biktarvy, about 2.6 times the volume of the typical Pennsylvania prescriber of this medication (76). Medicare paid an average of $3,998.56 per fill, versus $3,823.96 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average PA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 200 30-Day Fills standardized to 30-day supplies 6,000 Days of Medication total across all patients in 2023 | |||
| TriumeqAbacavir/Dolutegravir/Lamivudi | 138 | $3,755.43 | ▲ More than typical |
About Triumeq: This product contains 3 drugs: abacavir, dolutegravir, and lamivudine. Show more ▾ It is used to help control HIV infection. It helps to decrease the amount of HIV in your body so your immune system can work better. This lowers your chance of getting HIV complications (such as new infections, cancer) and improves your quality of life. Abacavir and lamivudine belong to a class of drugs known as nucleoside reverse transcriptase inhibitors (NRTIs). Dolutegravir belongs to a class of drugs known as integrase inhibitors. This medication is not a cure for HIV infection. To decrease your risk of spreading HIV disease to others, continue to take all HIV medications exactly as prescribed by your doctor. Use an effective barrier method (latex or polyurethane condoms/dental dams) during sexual activity as directed by your doctor. Do not share personal items (such as needles/syringes, toothbrushes, and razors) that may have contacted blood or other body fluids. Consult your doctor or pharmacist for more details. In 2023, this provider wrote 138 Medicare prescriptions for Triumeq, about 4.2 times the volume of the typical Pennsylvania prescriber of this medication (33). Medicare paid an average of $3,755.43 per fill, versus $3,571.36 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average PA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 138 30-Day Fills standardized to 30-day supplies 4,140 Days of Medication total across all patients in 2023 | |||
| GenvoyaElviteg/Cob/Emtri/Tenof Alafen | 102 | $4,507.14 | ▲ More than typical |
About Genvoya: This product is used to help control HIV infection. Show more ▾ It helps to decrease the amount of HIV in your body so your immune system can work better. This lowers your chance of getting HIV complications (such as new infections, cancer) and improves your quality of life. This product contains 4 different medications: elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide. Elvitegravir is known as an integrase inhibitor. Cobicistat helps elvitegravir work better. Emtricitabine is called a nucleoside reverse transcriptase inhibitor, while tenofovir alafenamide is called a nucleotide reverse transcriptase inhibitor; both kinds of drugs are often called NRTIs. Elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide is not a cure for HIV infection. To decrease your risk of spreading HIV disease to others, continue to take all HIV medications exactly as prescribed by your doctor. Use an effective barrier method (latex or polyurethane condoms/dental dams) during sexual activity as directed by your doctor. Do not share personal items (such as needles/syringes, toothbrushes, and razors) that may have contacted blood or other body fluids. Consult your doctor or pharmacist for more details. A pharmaceutical preparation of the ANTI-HIV AGENTS elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate that is used in the treatment of HIV INFECTIONS. In 2023, this provider wrote 102 Medicare prescriptions for Genvoya, about 3 times the volume of the typical Pennsylvania prescriber of this medication (34). Medicare paid an average of $4,507.14 per fill, versus $3,876.71 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average PA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 116 30-Day Fills standardized to 30-day supplies 3,480 Days of Medication total across all patients in 2023 | |||
| JulucaDolutegravir/Rilpivirine | 48 | $3,653.95 | ▲ More than typical |
About Juluca: Dolutegravir/rilpivirine is used to help control HIV infection. Show more ▾ It helps to decrease the amount of HIV in your body so your immune system can work better. This lowers your chance of getting HIV complications (such as new infections, cancer) and improves your quality of life. Dolutegravir is an integrase inhibitor while rilpivirine is a non-nucleoside reverse transcriptase inhibitor (NNRTI). Both drugs block the virus from growing and infecting more cells. Dolutegravir/rilpivirine is not a cure for HIV infection. To decrease your risk of spreading HIV disease to others, continue to take all HIV medications exactly as prescribed by your doctor. Use an effective barrier method (latex or polyurethane condoms/dental dams) during sexual activity as directed by your doctor. Do not share personal items (such as needles/syringes, toothbrushes, and razors) that may have contacted blood or other body fluids. Consult your doctor or pharmacist for more details. In 2023, this provider wrote 48 Medicare prescriptions for Juluca, about 1.5 times the volume of the typical Pennsylvania prescriber of this medication (32). Medicare paid an average of $3,653.95 per fill, versus $3,321.96 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average PA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 48 30-Day Fills standardized to 30-day supplies 1,440 Days of Medication total across all patients in 2023 | |||
| SymtuzaDarunavir/Cob/Emtri/Tenof Alaf | 45 | $4,982.83 | ▲ More than typical |
About Symtuza: This product is used to help control HIV infection. Show more ▾ It helps to decrease the amount of HIV in your body so your immune system can work better. This lowers your chance of getting HIV complications (such as new infections, cancer) and improves your quality of life. This product contains 4 different medications: darunavir, cobicistat, emtricitabine, and tenofovir alafenamide. Darunavir is known as a protease inhibitor. Cobicistat helps darunavir work better. Emtricitabine is called a nucleoside reverse transcriptase inhibitor, while tenofovir alafenamide is called a nucleotide reverse transcriptase inhibitor; both kinds of drugs are often called NRTIs. Darunavir/cobicistat/emtricitabine/tenofovir alafenamide is not a cure for HIV infection. To decrease your risk of spreading HIV disease to others, continue to take all HIV medications exactly as prescribed by your doctor. Use an effective barrier method (latex or polyurethane condoms/dental dams) during sexual activity as directed by your doctor. Do not share personal items (such as needles/syringes, toothbrushes, and razors) that may have contacted blood or other body fluids. Consult your doctor or pharmacist for more details. In 2023, this provider wrote 45 Medicare prescriptions for Symtuza, about 1.7 times the volume of the typical Pennsylvania prescriber of this medication (27). Medicare paid an average of $4,982.83 per fill, versus $4,567.62 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average PA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 45 30-Day Fills standardized to 30-day supplies 1,350 Days of Medication total across all patients in 2023 | |||
| PrezcobixDarunavir/Cobicistat | 25 | $2,945.11 | ≈ Typical |
About Prezcobix: This product is used with other HIV medications to help control HIV infection. Show more ▾ It helps to decrease the amount of HIV in your body so your immune system can work better. This lowers your chance of getting HIV complications (such as new infections, cancer) and improves your quality of life. This product is a combination of two different drugs: darunavir and cobicistat. Darunavir belongs to a class of drugs known as protease inhibitors. Cobicistat is used to increase (boost) the levels of darunavir. Darunavir/cobicistat is not a cure for HIV infection. To decrease your risk of spreading HIV disease to others, continue to take all HIV medications exactly as prescribed by your doctor. Use an effective barrier method (latex or polyurethane condoms/dental dams) during sexual activity as directed by your doctor. Do not share personal items (such as needles/syringes, toothbrushes, and razors) that may have contacted blood or other body fluids. Consult your doctor or pharmacist for more details. In 2023, this provider wrote 25 Medicare prescriptions for Prezcobix, about the same volume as the typical Pennsylvania prescriber of this medication (26). Medicare paid an average of $2,945.11 per fill, versus $2,380.28 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average PA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 29 30-Day Fills standardized to 30-day supplies 870 Days of Medication total across all patients in 2023 | |||
| AbacavirAbacavir Sulfate | 22 | $267.26 | ▲ More than typical |
About Abacavir: This drug is used with other HIV medications to help control HIV infection. Show more ▾ It helps to decrease the amount of HIV in your body so your immune system can work better. This lowers your chance of getting HIV complications (such as new infections, cancer) and improves your quality of life. Abacavir belongs to a class of drugs known as nucleoside reverse transcriptase inhibitors-NRTI. Abacavir is not a cure for HIV infection. To decrease your risk of spreading HIV disease to others, continue to take all HIV medications exactly as prescribed by your doctor. Use an effective barrier method (latex or polyurethane condoms/dental dams) during sexual activity as directed by your doctor. Do not share personal items (such as needles/syringes, toothbrushes, and razors) that may have contacted blood or other body fluids. Consult your doctor or pharmacist for more details. In 2023, this provider wrote 22 Medicare prescriptions for Abacavir, about 1.3 times the volume of the typical Pennsylvania prescriber of this medication (17). Medicare paid an average of $267.26 per fill, versus $265.74 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average PA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 28 30-Day Fills standardized to 30-day supplies 840 Days of Medication total across all patients in 2023 | |||
| DescovyEmtricitabine/Tenofov Alafenam | 20 | $2,719.73 | ▼ Less than typical |
About Descovy: This product is used with other HIV medications to help control HIV infection. Show more ▾ It helps to decrease the amount of HIV in your body so your immune system can work better. This lowers your chance of getting HIV complications (such as new infections, cancer) and improves your quality of life. This product is a combination of two different drugs: emtricitabine and tenofovir alafenamide. Emtricitabine is called a nucleoside reverse transcriptase inhibitor, while tenofovir alafenamide is called a nucleotide reverse transcriptase inhibitor. They are often called NRTIs. This product should not be used by itself to help control HIV infection. Doing so can make your treatment less effective. Use combination treatment with at least one other HIV medication. This product is also approved in the US to help prevent HIV infection in people who have a high risk for infection. Some things that increase risk include having a partner infected with HIV, having unprotected sex, having multiple sex partners, infection with a sexually transmitted disease-STD, or use/abuse of drugs or alcohol. Emtricitabine/tenofovir alafenamide is not a cure for HIV infection. To decrease your risk of spreading HIV disease to others, continue to take all HIV medications exactly as prescribed by your doctor. Use an effective barrier method (latex or polyurethane condoms/dental dams) during sexual activity as directed by your doctor. Do not share personal items (such as needles/syringes, toothbrushes, and razors) that may have contacted blood or other body fluids. Consult your doctor or pharmacist for more details. In 2023, this provider wrote 20 Medicare prescriptions for Descovy, about half the volume of the typical Pennsylvania prescriber of this medication (43). Medicare paid an average of $2,719.73 per fill, versus $2,162.16 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average PA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 24 30-Day Fills standardized to 30-day supplies 720 Days of Medication total across all patients in 2023 | |||
| Maraviroc | 20 | $1,337.97 | ≈ Typical |
About Maraviroc: Maraviroc is used with other HIV medications to help control HIV infection. Show more ▾ It helps to decrease the amount of HIV in your body so your immune system can work better. This lowers your chance of getting HIV complications (such as new infections, cancer) and improves your quality of life. Maraviroc belongs to a class of drugs known as entry inhibitors. It works by blocking the HIV virus from infecting healthy immune cells (T-cells). Maraviroc is not a cure for HIV infection. To decrease your risk of spreading HIV disease to others, continue to take all HIV medications exactly as prescribed by your doctor. Use an effective barrier method (latex or polyurethane condoms/dental dams) during sexual activity as directed by your doctor. Do not share personal items (such as needles/syringes, toothbrushes, and razors) that may have contacted blood or other body fluids. Consult your doctor or pharmacist for more details. A cyclohexane and triazole derivative that acts as an antagonist of the CCR5 RECEPTOR. It prevents infection by HIV-1 virus strains which use CCR5 as a co-receptor for membrane fusion and cellular entry. In 2023, this provider wrote 20 Medicare prescriptions for Maraviroc, about the same volume as the typical Pennsylvania prescriber of this medication (18). Medicare paid an average of $1,337.97 per fill, versus $1,001.81 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average PA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 20 30-Day Fills standardized to 30-day supplies 600 Days of Medication total across all patients in 2023 | |||
| OdefseyEmtricitab/Rilpiviri/Tenof Ala | 20 | $3,555.74 | ▼ Less than typical |
About Odefsey: This product contains 3 different medications: emtricitabine, rilpivirine, and tenofovir alafenamide. Show more ▾ It is used to help control HIV infection. It helps to decrease the amount of HIV in your body so your immune system can work better. This lowers your chance of getting HIV complications (such as new infections, cancer) and improves your quality of life. Emtricitabine and tenofovir alafenamide belong to a class of drugs known as nucleoside reverse transcriptase inhibitors (NRTIs). Rilpivirine belongs to a class of drugs known as non-nucleoside reverse transcriptase inhibitors (NNRTIs). Emtricitabine/rilpivirine/tenofovir alafenamide is not a cure for HIV infection. To decrease your risk of spreading HIV disease to others, continue to take all HIV medications exactly as prescribed by your doctor. Use an effective barrier method (latex or polyurethane condoms/dental dams) during sexual activity as directed by your doctor. Do not share personal items (such as needles/syringes, toothbrushes, and razors) that may have contacted blood or other body fluids. Consult your doctor or pharmacist for more details. In 2023, this provider wrote 20 Medicare prescriptions for Odefsey, about 69% of the volume of the typical Pennsylvania prescriber of this medication (29). Medicare paid an average of $3,555.74 per fill, versus $3,537.02 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average PA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 20 30-Day Fills standardized to 30-day supplies 600 Days of Medication total across all patients in 2023 | |||
| Lamivudine | 17 | $32.09▼ below PA avg | ≈ Typical |
About Lamivudine: This drug is used with other HIV medications to help control HIV infection. Show more ▾ It helps to decrease the amount of HIV in your body so your immune system can work better. This lowers your chance of getting HIV complications (such as new infections, cancer) and improves your quality of life. Lamivudine belongs to a class of drugs known as nucleoside reverse transcriptase inhibitors-NRTI. Lamivudine is not a cure for HIV infection. To decrease your risk of spreading HIV disease to others, continue to take all HIV medications exactly as prescribed by your doctor. Use an effective barrier method (latex or polyurethane condoms/dental dams) during sexual activity as directed by your doctor. Do not share personal items (such as needles/syringes, toothbrushes, and razors) that may have contacted blood or other body fluids. Consult your doctor or pharmacist for more details. A reverse transcriptase inhibitor and ZALCITABINE analog in which a sulfur atom replaces the 3' carbon of the pentose ring. It is used to treat HIV disease. In 2023, this provider wrote 17 Medicare prescriptions for Lamivudine, about the same volume as the typical Pennsylvania prescriber of this medication (17). Medicare paid an average of $32.09 per fill, versus $145.00 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average PA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the PA average for this medication. 17 30-Day Fills standardized to 30-day supplies 510 Days of Medication total across all patients in 2023 | |||
| TivicayDolutegravir Sodium | 14 | $2,213.58 | ▼ Less than typical |
About Tivicay: Dolutegravir is used with other HIV medications to help control HIV infection. Show more ▾ It helps to decrease the amount of HIV in your body so your immune system can work better. This lowers your chance of getting HIV complications (such as new infections, cancer) and improves your quality of life. Dolutegravir belongs to a class of drugs known as integrase inhibitors. It blocks the virus from growing and infecting more cells. Dolutegravir is not a cure for HIV infection. To decrease your risk of spreading HIV disease to others, continue to take all HIV medications exactly as prescribed by your doctor. Use an effective barrier method (latex or polyurethane condoms/dental dams) during sexual activity as directed by your doctor. Do not share personal items (such as needles/syringes, toothbrushes, and razors) that may have contacted blood or other body fluids. Consult your doctor or pharmacist for more details. In 2023, this provider wrote 14 Medicare prescriptions for Tivicay, about a third of the volume of the typical Pennsylvania prescriber of this medication (48). Medicare paid an average of $2,213.58 per fill, versus $2,202.90 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average PA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 14 30-Day Fills standardized to 30-day supplies 420 Days of Medication total across all patients in 2023 | |||
| Etravirine | 12 | $1,062.62▼ below PA avg | ▼ Less than typical |
About Etravirine: Etravirine is used with other HIV medications to help control HIV infection. Show more ▾ It helps to decrease the amount of HIV in your body so your immune system can work better. This lowers your chance of getting HIV complications (such as new infections, cancer) and improves your quality of life. This medication is usually prescribed to people who have taken other HIV medications (such as efavirenz, nevirapine, delavirdine) that did not work well enough to control their HIV. Etravirine is known as a non-nucleoside reverse transcriptase inhibitor (NNRTI). It blocks the virus from growing and infecting more cells. Etravirine is not a cure for HIV infection. To decrease your risk of spreading HIV disease to others, continue to take all HIV medications exactly as prescribed by your doctor. Use an effective barrier method (latex or polyurethane condoms/dental dams) during sexual activity as directed by your doctor. Do not share personal items (such as needles/syringes, toothbrushes, and razors) that may have contacted blood or other body fluids. Consult your doctor or pharmacist for more details. In 2023, this provider wrote 12 Medicare prescriptions for Etravirine, about half the volume of the typical Pennsylvania prescriber of this medication (22). Medicare paid an average of $1,062.62 per fill, versus $1,194.56 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average PA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the PA average for this medication. 12 30-Day Fills standardized to 30-day supplies 360 Days of Medication total across all patients in 2023 | |||
| Gabapentin | 11 | $16.78▼ below PA avg | ▼ Less than typical |
About Gabapentin: Gabapentin is used with other medications to prevent and control seizures. Show more ▾ It is also used to relieve nerve pain following shingles (a painful rash due to herpes zoster infection) in adults. Gabapentin is known as an anticonvulsant or antiepileptic drug. A cyclohexane-gamma-aminobutyric acid derivative that is used for the treatment of PARTIAL SEIZURES; NEURALGIA; and RESTLESS LEGS SYNDROME. In 2023, this provider wrote 11 Medicare prescriptions for Gabapentin, about 11% of the volume of the typical Pennsylvania prescriber of this medication (97). Medicare paid an average of $16.78 per fill, versus $21.72 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average PA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the PA average for this medication. 11 30-Day Fills standardized to 30-day supplies 330 Days of Medication total across all patients in 2023 | |||
About this data. The prescription history for MR. THOMAS JAMES LOVELESS MSN, CRNP, PHD is compiled from the Centers for Medicare & Medicaid Services (CMS) Medicare Part D Prescriber Public Use File for calendar year 2023, the most recent federal release. Figures cover prescriptions filled for Medicare Part D beneficiaries only; prescriptions under private insurance, Medicaid, or self-pay plans are not included. Because prescribing decisions are generally consistent across coverage types, this record offers a useful view of the overall Adult Health prescribing approach at this Southampton, PA practice.
Reading the costs. Drug costs are gross amounts paid to pharmacies under Part D, including both plan and beneficiary payments. They are not the price a patient pays at the pharmacy counter. Medications with fewer than 11 claims are excluded from the federal source data, and state comparisons use the average volume among PA prescribers of the same medication. Always confirm current medications and costs directly with the provider and your plan.
